CRISPR-edited immune cells can survive and thrive after infusion into cancer patients
Genetically-edited immune cells can persist, thrive, and function months after a cancer patient receives them, according to new data published by researchers from the Abramson Cancer Center of the University of Pennsylvania. ...
Feb 6, 2020
0
380